LGC appoints Vivid Sehgal as Chief Financial Officer

News (ZH) - Replaces Simon Parsons, who will leave LGC after 11 years of service

Ampersand-backed Alliance Pharma to acquire LGC’s Drug Development Solutions Business (“DDS”) and welcomes KKR as joint shareholder

News (ZH) - DDS is a European provider of Bioanalytical and Analytical and Materials Science Solutions to pharma, biopharma, consumer healthcare and consumer products clients, located in Cambridge and Sandwich, UK

LGC’s new state-of-the-art site in Oxford will deliver critical diagnostics solutions and research

News (ZH) - Facility will serve as home of The Native Antigen Company and an advanced workflow applications laboratory for LGC Biosearch Technologies